miR-155 potentiates the development of both regulatory T cells (Treg) and T helper 17 (Th17) cell subsets while augmenting IL-17A secretion through SOCS1 targeting, thereby influencing immune tolerance and autoimmune diseases [48]. This evidence concerns the gene IL17A and autoimmune disease.